# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Roald Amundsen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EX003-SYN
- Date: 2026-06-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ingrid Solheim-Achebe, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Seventeen-week review of finger pain, the ankle sprain, and the risks of an Arctic air search flight. **S**

## History of present illness

Mr. Amundsen returns three weeks after spraining his right ankle. The swelling has gone, he walks normally with the brace, and he stopped the diclofenac gel after two weeks. He did not take tramadol. His average finger pain over the past week is 2 of 10, and he has had no drowsiness on duloxetine. He has been asked to join an Arctic air search for the missing crew of an airship, flying over the sea ice, and he wants to discuss the medical risks before he decides. He has had no chest pain, palpitations, or breathlessness. **S**

| Element | Detail |
|---|---|
| Finger pain | Average 2 of 10 over the past week |
| Ankle | Walking normally in the brace; gel stopped after two weeks |
| Medicine effects | No drowsiness or dizziness |
| Question | Medical risks of an Arctic air search flight |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, or breathlessness |
| Neurological | Positive | Mild finger burning on cold mornings only |
| Musculoskeletal | Positive | Slight ankle stiffness in the mornings; old shoulder stiffness |
| Psychiatric | Negative | Mood good; sleeping well |

4 systems reviewed. **S**

## Current medications

- Capsaicin 0.075% cream, a small amount rubbed into the painful fingers four times a day; wash hands after use and keep away from the eyes **S**
- Duloxetine 60 mg delayed-release capsule, one capsule by mouth daily; do not stop suddenly **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 64 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 78.4 kg; BMI 23.4 kg/m². All vital signs are synthetic.

Finger pain, 0 to 10: 2. All results are synthetic.

## Change since baseline

- Finger pain, 0 to 10: 6 at baseline, 2 at this visit **S**

## Immunizations given today

- Recombinant zoster vaccine, dose 2 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 128/80, pulse 64, weight 78.4 kg |
| Cardiovascular | Regular rhythm; no murmur |
| Right ankle | No swelling; mild tenderness over the anterior talofibular ligament; single-leg stance for 20 seconds |
| Right shoulder | Forward flexion and abduction to about 120 degrees; strength good |
| Hands | Fingertips cool; skin intact |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-frostbite neuropathic pain of the fingers, well controlled** (M79.2). Average pain 2 of 10 on duloxetine 60 mg, without drowsiness; blood pressure 128/80, back near his baseline. **S**
   - Continue duloxetine 60 mg daily; carry the whole supply when travelling and never stop it suddenly.
   - Capsaicin cream on cold days.
2. **Right ankle sprain, recovering** (S93.401A). Walking normally; balance good. **S**
   - Brace on rough ground and ice for another four weeks; continue balance exercises.
3. **Risks of an Arctic air search flight**. A risk discussion, at his request; the decision is his. ECG today: sinus rhythm, no abnormality. No sign of heart disease on history and examination; blood pressure at target. The main medical risks are environmental: cold-water immersion after any forced landing on open water, with cold shock in the first minutes and hypothermia later; and cold injury, to which his previously frostbitten fingers are more vulnerable. His old shoulder fracture limits overhead reach, which matters for climbing out of an aircraft or into a raft. Stopping duloxetine suddenly would cause dizziness and other withdrawal effects. **S**
   - An immersion suit and life jacket worn over the water, with a survival kit, signalling equipment, and dry insulated clothing.
   - Practise the exit from the aircraft and boarding the raft with the shoulder's limits in mind.
   - Heated gloves, spare mittens, hand warmers; rewarm frostbitten skin only when it can be kept from refreezing; insulate and handle any hypothermic person gently.
   - Carry the medical summary, the advance care plan, a full supply of duloxetine, and capsaicin cream.
   - Second recombinant zoster vaccine dose given today.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pain severity (0 to 10 numeric rating) and overall improvement | Every review, and early after starting or changing a medicine | Completed today | Average 2 of 10 |
| Medication safety | Adverse effects, especially drowsiness, dizziness and nausea | Every review, and early after starting or changing a medicine | Completed today | No drowsiness or dizziness |
| Examination | Daily activities and participation: fine hand tasks in the cold, driving, flying | Every review, and early after starting or changing a medicine | Completed today | Fine hand tasks manageable with gloves; driving; asked about flying |
| Survey | Mood (PHQ-9) and anxiety | Every review, and early after starting or changing a medicine | Up to date | PHQ-9 3 five weeks ago; mood good by interview |
| Examination | Sleep quality | Every review, and early after starting or changing a medicine | Completed today | Sleeping well |
| Examination | Blood pressure | Before starting duloxetine and periodically on it | Completed today | 128/80 mmHg |
| Laboratory | Sodium and liver enzyme (ALT) on duloxetine | Baseline, then once in the first weeks of treatment | Up to date | Normal five weeks ago |
| Medication safety | Interactions: no tramadol or other serotonergic drugs; caution with oral NSAIDs; alcohol | Every review | Completed today | No tramadol after the sprain; diclofenac gel only, now stopped |
| Medication safety | Continuation and withdrawal: no abrupt stopping; taper if stopping | Every review, and before travel | Completed today | Full supply to carry; never stop suddenly |
| Self-management | Skin of the fingers and cold protection | Every review, and early after starting or changing a medicine | Completed today | Skin intact; cold protection plan for the flight |

## Goal progress

- Average finger pain at or below 3 of 10, with fewer cold attacks, by four months. Outcome by 2026-06-09: Average pain 2 of 10 on duloxetine 60 mg; cold attacks shorter and less frequent. **S**
- Able to handle buttons, keys and a pen outdoors in the cold with protective gloves. Outcome by 2026-05-05: Managing with liner and heated gloves and hand warmers. **S**
- Any medicine used causes no daytime drowsiness that affects driving or flying. Outcome by 2026-06-09: No drowsiness on capsaicin cream or duloxetine. **S**

## Guideline basis

- Neuropathic pain in adults: pharmacological management in non-specialist settings (CG173) (2013, updated 2020), National Institute for Health and Care Excellence
- Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (McIntosh SE, et al. Wilderness Environ Med 2024;35(2):183-197) (2024), Wilderness Medical Society
- Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (Dow J, et al. Wilderness Environ Med 2019;30(4S):S47-S69) (2019), Wilderness Medical Society
- Diagnosis, treatment and prevention of ankle sprains: update of an evidence-based clinical guideline (Vuurberg G, et al. Br J Sports Med 2018;52(15):956) (2018), British Journal of Sports Medicine

## Follow-up

- Review in three months, sooner after any journey. A written summary of the flight risk discussion was given to him. **S**

